Israel Lowy

Senior Vice President, Translational Sciences & Oncology at Regeneron Pharmaceuticals, Inc.

Israel Lowy

Israel Lowy

Senior Vice President, Translational Sciences & Oncology at Regeneron Pharmaceuticals, Inc.

Biography

Israel (Izzy) Lowy, MD, PhD, joined Regeneron in 2010 as Vice President, and serves as the Senior Vice President, Translational Sciences and Oncology. He is a primary architect of Regeneron’s cancer immunotherapy program. Prior to joining Regeneron, Dr. Lowy was at Medarex for eight years. Previously, he was Assistant Professor of Medicine and Microbiology at Mount Sinai School of Medicine. He is a licensed physician and has been board certified in internal medicine and infectious diseases. Dr. Lowy received his AB in Biochemical Sciences from Princeton University and his MD-PhD in Biochemistry and Molecular Biophysics from Columbia University.

Overview
RelSci Relationships

233

Contact Data
Trying to get in touch with Israel Lowy? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Israel Lowy likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder, President & Chief Executive Officer at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Founding Scientist at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Director, Public Policy at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Director, Clinical Sciences at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Financial Officer & Executive Vice President-Finance at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Secretary, Executive Vice President & General Counsel at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Vice President & General Manager, Industrial Operations & Product Supply at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Vice President, Head, Regeneron Genetics Center at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Senior Director at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Senior Director Clinical Finance at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Israel Lowy
Potential Connections via
Relationship Science
You
Israel Lowy
Senior Vice President, Translational Sciences & Oncology at Regeneron Pharmaceuticals, Inc.
Career History
Senior Vice President, Translational Sciences & Oncology
Current

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Other Affiliations

Israel Lowy is affiliated with Regeneron Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Israel Lowy. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Israel Lowy's profile does not indicate a business or promotional relationship of any kind between RelSci and Israel Lowy.